IMR Press / CEOG / Volume 44 / Issue 4 / DOI: 10.12891/ceog3614.2017

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 46 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with S.O.G.

Open Access Original Research
Effect of borderline glucose intolerance on fetal maternal outcome
Show Less
1 Department of Obstetrics and Gynecology, Istanbul University Cerrahpasa Medical Faculty, Istanbul, Turkey
2 Zeynep Kamil Research Hospital, Istanbul, Turkey
3 Department of Gynecology and Obstetrics, Ben Gurion University, Barzilai Hospital, Ashkelon, Israel
Clin. Exp. Obstet. Gynecol. 2017, 44(4), 562–565;
Published: 10 August 2017
Purpose of investigation: The aim of this study was to compare the maternal and neonatal adverse outcomes in pregnant women whose glucose challenge test (GCT) results were below 130 mg/dl and between 130-139 mg/dl. Materials and Methods: Three hundred and six women with 50-gram GCT results of 130-139 mg/dl and 305 women with 50-gram GCT results of < 130 mg/dl were recruited. Results: Higher pre-postpartum hemoglobin difference (p = 0.001), longer postpartum hospitalisation time (p = 0.001), and increased cesarean section rates (p = 0.01) were reported in the study group. There were no differences between two groups in rates of preeclampsia, polyhydramnios, ablatio placenta, and chorioamnionitis. Conclusions: The authors suggest that a GCT result between 130-139 mg/dl is not associated with higher maternal and neonatal morbidity. Results do not support a conclusion of high maternal and neonatal morbidity in the study group and give an impression that the 140 mg/dl threshold value is adequate for screening.
Gestational diabetes mellitus
Glucose challenge test
Neonatal morbidity
Back to top